688553 匯宇製藥
按盤價 
12.760 +2.130 (+20.038%) | 2026/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 269,207 | 12.61% | 998,145 | 1,094,382 | 927,075 | 1,493,268 | |
| 減：營業總成本 | 241,878 | 15.71% | 923,789 | 1,006,585 | 873,712 | 1,304,312 | |
| 其中:營業成本 | 56,060 | 43.16% | 203,595 | 181,511 | 130,447 | 176,182 | |
| 財務費用 | 2,730 | -130.67% | (48,771) | (22,120) | (41,802) | (46,899) | |
| 資產減值損失 | (1,966) | 16.67% | (5,406) | (14,814) | (2,307) | (3,933) | |
| 公允價值變動收益 | (27,687) | -66.17% | (167,004) | 239,856 | 6,440 | 2,327 | |
| 投資收益 | 7,585 | 978.51% | 477 | 13,815 | 34,183 | 42,894 | |
| 其中：對聯營企業和合營企業的投資收益 | -- | -- | (752) | (2,687) | 307 | 1,471 | |
| 營業利潤 | 15,991 | -136.49% | (66,225) | 348,432 | 124,368 | 235,448 | |
| 利潤總額 | 16,510 | -138.27% | (64,313) | 349,699 | 132,154 | 238,391 | |
| 減：所得稅費用 | (5,210) | -68.32% | (33,765) | 33,802 | (7,180) | (10,599) | |
| 淨利潤 | 21,720 | -181.39% | (30,548) | 315,897 | 139,335 | 248,991 | |
| 減：非控股權益 | (149) | -85.92% | (5,586) | (9,493) | (451) | -- | |
| 股東淨利潤 | 21,869 | -185.34% | (24,961) | 325,390 | 139,786 | 248,991 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.050 | -183.33% | -0.060 | 0.770 | 0.330 | 0.590 | |
| 每股派息 (元) * | -- | -- | 0.200 | 0.463 | 0.213 | 0.235 | |
| 每股淨資產 (元) * | 8.925 | -4.35% | 8.872 | 9.393 | 8.901 | 8.777 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 01/07/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
